GB Sciences Statistics
Total Valuation
GB Sciences has a market cap or net worth of 40,707. The enterprise value is 2.03 million.
| Market Cap | 40,707 |
| Enterprise Value | 2.03M |
Important Dates
The last earnings date was Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GB Sciences has 407.07 million shares outstanding. The number of shares has increased by 4.24% in one year.
| Current Share Class | 407.07M |
| Shares Outstanding | 407.07M |
| Shares Change (YoY) | +4.24% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.67% |
| Owned by Institutions (%) | n/a |
| Float | 400.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.42 |
| PB Ratio | -0.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.93 |
| EV / Sales | 20.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.36 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -438.99% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 15.94% |
| Revenue Per Employee | 48,618 |
| Profits Per Employee | -527,753 |
| Employee Count | 2 |
| Asset Turnover | 0.80 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.81% in the last 52 weeks. The beta is 9.86, so GB Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 9.86 |
| 52-Week Price Change | -92.81% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 43.76 |
| Average Volume (20 Days) | 32,147 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, GB Sciences had revenue of 97,235 and -1.06 million in losses. Loss per share was -0.00.
| Revenue | 97,235 |
| Gross Profit | 97,235 |
| Operating Income | -848,406 |
| Pretax Income | -1.04M |
| Net Income | -1.06M |
| EBITDA | -847,938 |
| EBIT | -848,406 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 3,016 in cash and 1.99 million in debt, giving a net cash position of -1.99 million or -0.00 per share.
| Cash & Cash Equivalents | 3,016 |
| Total Debt | 1.99M |
| Net Cash | -1.99M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -5.88M |
| Book Value Per Share | -0.01 |
| Working Capital | -5.32M |
Cash Flow
| Operating Cash Flow | -506,443 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -872.53% |
| Pretax Margin | -1,072.60% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GB Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.24% |
| Shareholder Yield | n/a |
| Earnings Yield | -2,592.93% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GB Sciences has an Altman Z-Score of -1735.7 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1735.7 |
| Piotroski F-Score | 1 |